Table 2.
Clinical and Laboratory Data of the Study Cohort
| Hypertension Group | Non‐Hypertension Group | Entire Cohort | P Value | |
|---|---|---|---|---|
| Patients, No. (%) | 142 (73) | 53 (27) | 195 (100) | |
| Systolic value | 177.64±22.60 | 168.59±17.98 | 175.19±21.79 | .011 |
| Diastolic value | 106.13±16.94 | 95.2±12.19 | 103.16±16.46 | <.001 |
| Pulse pressure | 71.51±17.8 | 73.39±20.5 | 72.03±19.3 | .549 |
| Heart rate | 86.06±16.24 | 90.04±18.21 | 87.14±16.91 | .149 |
| VAS score | 2.34±3.04 | 3.55±3.02 | 2.74±3.12 | .04 |
| Creatinine, mg/dL | 0.79±0.2 | 0.73±0.18 | 0. 0.77±0.2 | .044 |
| Urea | 30.94±8.58 | 29.65±8.59 | 30.6±8.56 | .356 |
| EGFR (MDRD), mg/dL | 97.48±24.75 | 105.63±29.02 | 99.64±25.99 | .058 |
| Sodium, mg/dL | 35±2.54 | 138.33±2.60 | 138.36±2.55 | .964 |
| Potassium, mg/dL | 4.14±0.38 | 4.22±0.38 | 4.17±0.39 | .162 |
| Troponin, mg/dLa | 0.02±0.04 | 0.01 | 0.02±0.04 | .101 |
Abbreviations: MAP, mean arterial pressure; MDRD, Modification of Diet in Renal Disease; VAS, visual analog scale. aTroponin level after excluding patients with estimated glomerular filtration rate (eGFR) <60 mg/dL. Values are expressed as mean±standard deviation unless otherwise indicated.